Registry following patients with several cancers treated by MR-Linac radiation therapy
Records outcomes of cancer patients receiving radiation therapy with the Unity MR-Linac machine.
Plain-language title generated from the registry record
Registry title: The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Key facts
- Where
- Brussels, BelgiumSee the site
Where in Belgium
- Insitut Jules BordetBrussels, BelgiumNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- UMC Utrecht
- Trial code
- NCT04075305
- Record updated
- 5 March 2026
- Original description
The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpose to improve patients' survival, local, and regional tumor control and quality of life.Read full original descriptionShow less
The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpose to improve patients' survival, local, and regional tumor control and quality of life.
Inclusion: Patient is to undergo or has completed imaging or treatment procedures on an MR-Linac; Patient provides written, informed consent; Patient is 18 years old or older.
Exclusion: MRI contraindications as per usual clinical care, such as (possible) pregnancy; claustrophobia and metal or electronic implants not compatible with MRI; MRI exclusion criteria, including.